Clinically feasible MTR is sensitive to cortical demyelination in MS.

Tien-Hsiang Chen J, Easley K, Schneider C, Nakamura K, Kidd GJ, Chang A, Staugaitis SM, Fox RJ, Fisher E, Arnold DL, et al.